Radiotherapy Trials
Radiotherapy clinical trials were established in Beacon in 2009. The trials unit was created with the aim of carrying out high quality cancer research by means of clinical trials on the use of new techniques for the benefit of all patients. This has been achieved through the participation of and collaboration with National and International clinical trials groups from US, UK, Canada, Australia as well as active memberships with Cancer Trials Ireland, IRROG (Irish Radiotherapy Research Oncology Group) and EORTC (European Organisation for Research and Treatment of Cancer).
Currently Accruing:
CTRIAL-IE 18-33: Source Lung: “Stereotactic ablative radiation therapy of ultracentra lung tumours”
CTRIAL-IE 19-21: SABR COMET 3: Phase III randomized controlled trial and economic evaluation of stereotactic ablative radiotherapy for comprehensive treatment of oligostatic (1-3 metastases) cancer”
CTRIAL-IE 20-03: Spine SABR: “Dose-escalated stereotactic ablative body radiotherapy for solid tumor spine metastases”
CTRIAL 21-28: E2-RADIate: “EORTC-ESTRO RADiotherapy InfrAstructure for Europe”
CTRIAL-IE 22-17: SAMURAI: “Randomized phase II stereotactic radiosurgery/stereotactic body radiation therapy for metatstatic unresected renal cell carcinoma receiving immunotherapy”
